Cheng Leng Chan

452 total citations
15 papers, 254 citations indexed

About

Cheng Leng Chan is a scholar working on Toxicology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Cheng Leng Chan has authored 15 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Toxicology, 4 papers in Infectious Diseases and 4 papers in Pharmacology. Recurrent topics in Cheng Leng Chan's work include Pharmacovigilance and Adverse Drug Reactions (6 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Drug-Induced Adverse Reactions (3 papers). Cheng Leng Chan is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (6 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Drug-Induced Adverse Reactions (3 papers). Cheng Leng Chan collaborates with scholars based in Singapore, Australia and United Kingdom. Cheng Leng Chan's co-authors include Bee Choo Tai, Zhaojin Chen, Gilbert Lau, Hio Teng Leong, Shu Chuen Li, Cynthia Sung, Ganga Ganesan, Robert Gan, Alvin Wai Kit Tan and John Abisheganaden and has published in prestigious journals such as Radiology, Frontiers in Pharmacology and Drug Safety.

In The Last Decade

Cheng Leng Chan

15 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng Leng Chan Singapore 8 80 68 38 35 33 15 254
Ariola Koci Italy 10 46 0.6× 76 1.1× 32 0.8× 25 0.7× 60 1.8× 16 386
Louis Létinier France 9 29 0.4× 83 1.2× 15 0.4× 32 0.9× 18 0.5× 22 285
Hoi Y. Tong Spain 12 120 1.5× 31 0.5× 22 0.6× 36 1.0× 86 2.6× 26 385
Elena Arzenton Italy 9 58 0.7× 52 0.8× 10 0.3× 26 0.7× 51 1.5× 19 285
H. Karl Greenblatt United States 8 31 0.4× 25 0.4× 16 0.4× 19 0.5× 23 0.7× 10 231
Alexandre O. Gérard France 11 54 0.7× 66 1.0× 212 5.6× 66 1.9× 17 0.5× 37 475
Michaela Winkler Germany 13 85 1.1× 123 1.8× 107 2.8× 15 0.4× 26 0.8× 18 611
Xin Hai China 11 28 0.3× 23 0.3× 20 0.5× 46 1.3× 9 0.3× 18 525
Camille Lenoir Switzerland 9 44 0.6× 10 0.1× 33 0.9× 42 1.2× 83 2.5× 13 258
Driss Berdaï France 9 39 0.5× 62 0.9× 13 0.3× 25 0.7× 8 0.2× 33 230

Countries citing papers authored by Cheng Leng Chan

Since Specialization
Citations

This map shows the geographic impact of Cheng Leng Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Leng Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Leng Chan more than expected).

Fields of papers citing papers by Cheng Leng Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Leng Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Leng Chan. The network helps show where Cheng Leng Chan may publish in the future.

Co-authorship network of co-authors of Cheng Leng Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Leng Chan. A scholar is included among the top collaborators of Cheng Leng Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Leng Chan. Cheng Leng Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chan, Cheng Leng, et al.. (2024). The Problems with Online Health Product Sales: How can Regulations be Improved?. Drug Safety. 47(6). 529–533. 2 indexed citations
2.
Chan, Cheng Leng, Toon Wei Lim, Yean Teng Lim, et al.. (2024). An updated analysis on myocarditis and pericarditis cases reported following mRNA SARS-CoV-2 vaccination in Singapore. Singapore Medical Journal. 3 indexed citations
3.
Chan, Cheng Leng, et al.. (2023). Nationwide safety surveillance of COVID-19 mRNA vaccines following primary series and first booster vaccination in Singapore. Vaccine X. 15. 100419–100419. 5 indexed citations
4.
Yap, Jonathan, Cheng Leng Chan, Toon Wei Lim, et al.. (2022). Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting. Annals of the Academy of Medicine Singapore. 51(2). 1 indexed citations
5.
Yap, Jonathan, Cheng Leng Chan, Toon Wei Lim, et al.. (2022). Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting. Annals of the Academy of Medicine Singapore. 51(2). 96–100. 21 indexed citations
6.
7.
Chan, Cheng Leng, et al.. (2020). Quantitative data mining in signal detection: the Singapore experience. Expert Opinion on Drug Safety. 19(5). 633–639. 2 indexed citations
8.
9.
10.
Chen, Zhaojin, et al.. (2016). Data mining spontaneous adverse drug event reports for safety signals in Singapore – a comparison of three different disproportionality measures. Expert Opinion on Drug Safety. 15(5). 583–590. 82 indexed citations
11.
Pang, S. M., Shih Hui Lim, T Thirumoorthy, et al.. (2014). Building pharmacogenetics into a pharmacovigilance program in Singapore: using serious skin rash as a pilot study. The Pharmacogenomics Journal. 14(4). 316–321. 29 indexed citations
12.
Thambiah, Joseph, et al.. (2009). Necrotising Fasciitis Caused by Adulterated Traditional Asian Medicine: A Case Report. Journal of orthopaedic surgery. 17(2). 223–226. 4 indexed citations
13.
Lim, C. C. Tchoyoson, Robert Gan, Cheng Leng Chan, et al.. (2008). Severe Hypoglycemia Associated with an Illegal Sexual Enhancement Product Adulterated with Glibenclamide: MR Imaging Findings. Radiology. 250(1). 193–201. 26 indexed citations
14.
Lau, Gilbert, et al.. (2004). 1. A Fatal Case of Hepatic Failure Possibly Induced by Nitrosofenfluramine. Medicine Science and the Law. 44(3). 252–263. 29 indexed citations
15.
Lau, Gilbert & Cheng Leng Chan. (2002). Massive Hepatocellular Necrosis: Was it Caused by Orlistat?. Medicine Science and the Law. 42(4). 309–312. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ariola Koci Breakdown of academic impact, for papers by Louis Létinier Breakdown of academic impact, for papers by Hoi Y. Tong Breakdown of academic impact, for papers by Elena Arzenton Breakdown of academic impact, for papers by H. Karl Greenblatt Breakdown of academic impact, for papers by Alexandre O. Gérard Breakdown of academic impact, for papers by Michaela Winkler Breakdown of academic impact, for papers by Xin Hai Breakdown of academic impact, for papers by Camille Lenoir Breakdown of academic impact, for papers by Driss Berdaï
Rankless by CCL
2026